Gerda de Kuijper is an intellectual disability (ID) physician. She graduated as a medical doctor in 1980, as an ID physician in 2000, and as a PhD in 2013. She carried out her PhD project from 2008-2013 at the University Medical Center Groningen, the Netherlands. The subject of the project was “Aspects of long-term use of antipsychotic drugs on an off-label base in individuals with intellectual disability”. She has worked as a GP in primary care (1982-1988), in youth healthcare (1982-1994), and as an ID physician in mental healthcare and ID care settings (1993-2023). Her research interests are diagnostics and treatment of mental disorders and challenging behavior and the organization of mental healthcare for people with ID. She is an expert in psychopharmacology. She was a member of working groups in the development of guidelines: 1) the Dutch guideline on Psychotropic drug prescription in people with ID (published in 2008, revision in 2016), 2) the multidisciplinary Dutch guideline on Problem behavior in adults with ID (published in 2018), and 3) the multidisciplinary guideline on “Self-management of adults with disabilities or chronic disorders in vulnerable groups (2023). She was one of the founders of the Academic Collaboration Intellectual Disability and Mental Health, UMCG, which was founded in 2019. In 2022, she received the “Hannah Oorthuys” award from the Dutch Association of ID Physicians for her contributions to the research and practice of ID medicine.
Gerda de Kuijper is an intellectual disability (ID) physician. She graduated as a medical doctor in 1980, as an ID physician in 2000, and as a PhD in 2013. She carried out her PhD project from 2008-2013 at the University Medical Center Groningen, the Netherlands. The subject of the project was “Aspects of long-term use of antipsychotic drugs on an off-label base in individuals with intellectual disability”. She has worked as a GP in primary care (1982-1988), in youth healthcare (1982-1994), and as an ID physician in mental healthcare and ID care settings (1993-2023). Her research interests are diagnostics and treatment of mental disorders and challenging behavior and the organization of mental healthcare for people with ID. She is an expert in psychopharmacology. She was a member of working groups in the development of guidelines: 1) the Dutch guideline on Psychotropic drug prescription in people with ID (published in 2008, revision in 2016), 2) the multidisciplinary Dutch guideline on Problem behavior in adults with ID (published in 2018), and 3) the multidisciplinary guideline on “Self-management of adults with disabilities or chronic disorders in vulnerable groups (2023). She was one of the founders of the Academic Collaboration Intellectual Disability and Mental Health, UMCG, which was founded in 2019. In 2022, she received the “Hannah Oorthuys” award from the Dutch Association of ID Physicians for her contributions to the research and practice of ID medicine.